Laxmi Organic Industries Ltd Q1 FY27 Earnings Analysis
Published 31 May 2026 | Chemicals & Petrochemicals | Market Cap: ₹4.2K Cr
Price
₹149
Market Cap
₹4.2K Cr
P/E Ratio
53.1
Revenue Rank
Margin Rank
Earnings Summary
- Dahej project's full impact on revenues to be seen from the second half of FY '27, with gradual ramp-up into FY '28 and beyond. - Phase 2 of Dahej is expected to commence operations in Q1 FY '27; Hitachi plant to start in Q2 FY '27. - Management expects Specialty business growth post-ramp-up of new capacities, especially from second half FY '27. - Revenue guidance shared: approx. - Laxmi Organic anticipates strong growth in FY '27 and beyond, driven by new capacities coming online, especially the Dahej Phase 2 and Hitachi projects.
📊 Revenue & Sales Performance
Rank 3- Dahej project's full impact on revenues to be seen from the second half of FY '27, with gradual ramp-up into FY '28 and beyond. - Phase 2 of Dahej is expected to commence operations in Q1 FY '27; Hitachi plant to start in Q2 FY '27. - Management expects Specialty business growth post-ramp-up of new capacities, especially from second half FY '27. - Revenue guidance shared: approx. INR 3,700-4,000 crores in FY '27 and around INR 5,000 crores in FY '28. - Specialty segment growth depends on product ramp-up and contract fulfillment timelines. - Overall, the company is geared for growth, tapping controllable levers prudently and strengthening customer relations. - Cautious optimism owing to evolving chemical industry dynamics; exact numbers awaited as the situation stabilizes.
📈 Profitability & Margins
Rank 3- Laxmi Organic anticipates strong growth in FY '27 and beyond, driven by new capacities coming online, especially the Dahej Phase 2 and Hitachi projects. - Dahej project (INR1,000 crore investment) revenue impact expected primarily in H2 FY '27 with gradual ramp-up into FY '28. - Hitachi plant to start quarter 3 FY '27, with steady qualification and ramp-up thereafter under a multiyear contract. - Specialty business expected to grow as deferred orders normalize and pricing stabilizes post-crisis. - Management is cautiously optimistic, focusing on prudent working capital management and judicious investment. - Exact financial numbers or EPS guidance were not provided due to volatile market conditions; management prefers to wait until situation stabilizes for clearer outlook. - Overall, the company is "geared for growth and to win," expecting improved revenues between INR3,700-4,000 crores in FY '27 and close to INR5,000 crores in FY '28.
🏗️ Capital Expenditure Plans
Yes- Dahej project investment of approximately INR 1,000 crores, with asset turnover blending capex between Essentials and Specialties businesses. - Phase 2 of the Dahej plant chemical charging scheduled for Q1 FY '27, with sampling to customers starting thereafter; revenue impact expected from second half of FY '27. - Hitachi plant to commence operations in Q2 FY '27 with steady qualification and ramp-up planned; supported by a multiyear contract. - Post these projects' commissioning, no near-term capex planned, indicating the current capex cycle is largely complete. - Focus on judicious investment and working capital management to support growth. - Supply chain digitization project expected to go live in Q2 FY '27 to enhance operational efficiency. - Emphasis on responsible and sustainable manufacturing practices with improved water and energy intensity metrics.
💰 Fundraising & Capital Structure
No information- There is no mention of any current or planned fundraising through debt or equity in the provided transcript. - The management discusses significant capital expenditure on the Dahej project (~INR 1,000 crores) and other capacity expansions. - The Dahej Phase 2 and Hitachi projects are expected to start operations around Q1 and Q2 FY '27 respectively, indicating ongoing investment but no new fundraising announcement. - The company emphasizes prudent working capital management, which supports investment in growth projects. - No direct references to new debt or equity fundraising plans were made during the call.
📋 Order Book & Pipeline
Yes- Laxmi Organic Industries reported a good order book position as they entered FY '27, particularly at their fluorination setup at Lote. - The company has started dispatches from the new world-scale ethyl acetate setup line at Lote. - Phase 2 of the Dahej plant's chemical charging is set for Q1 FY '27, with sampling to customers starting then; revenues are expected from Dahej in the second half of FY '27. - They have multi-year contracts for some projects (e.g., Hitachi plant), with steady qualification and ramp-up underway. - The management emphasized a cautious yet optimistic ramp-up of ongoing projects and expects stronger revenue manifestation in FY '27 and beyond as capacities come online and order execution progresses.
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Laxmi Organic Industries Ltd Q1 FY27 results?
- Dahej project's full impact on revenues to be seen from the second half of FY '27, with gradual ramp-up into FY '28 and beyond. - Phase 2 of Dahej is expected to commence operations in Q1 FY '27; Hitachi plant to start in Q2 FY '27. - Management expects Specialty business growth post-ramp-up of new capacities, especially from second half FY '27. - Revenue guidance shared: approx. - Laxmi Organic anticipates strong growth in FY '27 and beyond, driven by new capacities coming online, especially the Dahej Phase 2 and Hitachi projects.
What is Laxmi Organic Industries Ltd share price analysis?
Laxmi Organic Industries Ltd currently shows a below-average growth signal. The stock trades at a P/E of 53.1 with a market cap of ₹4,227. Investors should review the full earnings analysis for detailed insights.
Is Laxmi Organic Industries Ltd planning capital expenditure?
- Dahej project investment of approximately INR 1,000 crores, with asset turnover blending capex between Essentials and Specialties businesses.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
